Open Access

Building the evidence base for cardiac interventions in non-valvular atrial fibrillation.

Congress Session

About the speaker

Professor Renato Lopes

Duke University Medical Center, Durham (United States of America)
20 presentations
0 follower

3 more presentations in this session

Welcome: The shifting risk/benefit balance of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation and cardiac interventions.

Speaker: Professor I. Van Gelder (Groningen, NL)


Antithrombotic therapy in patients with transcatheter aortic valve implantation: Balancing risks with benefits.

Speaker: Professor J. ten Berg (Nieuwegein, NL)


Panel Q&A.


Access the full session

Optimising oral anticoagulation for atrial fibrillation patients undergoing cardiac interventions in 2021: From evidence to practice

Speakers: Professor R. Lopes, Professor I. Van Gelder, Professor J. ten Berg

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Hot topics in ventricular tachycardia.

5 April 2022

EHRA Premium Access

Hot topics in atrial fibrillation.

5 April 2022

ESC Premium Access

Future treatments for lipoprotein(a).

27 August 2021

This platform is supported by

logo Novo Nordisk